Access and Authority

Congressional lawmakers have introduced a bill that would enable terminally ill patients to more easily try experimental drugs, Pharmalot's Ed Silverman reports. The bill, Silverman adds, would prevent the federal government, including the Food and Drug Administration and the Drug Enforcement Administration, from impeding access.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.